Fig. 2From: Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studiesStability of [177Lu]Lu-rhPSMA-10.1 (blue) and [177Lu]Lu-rhPSMA-10.2 (green) in acetate buffer (pH 5.5), PBS pH 7.4, 0.9% sodium chloride and human serum at 37 °C. Radionuclide incorporation (RNI; %) was determined in triplicate via radio-TLC after incubation for 1 to 168 hBack to article page